BCDA
Price
$2.35
Change
+$0.04 (+1.73%)
Updated
Jul 25 closing price
Capitalization
12.96M
SMMT
Price
$28.67
Change
+$1.10 (+3.99%)
Updated
Jul 25 closing price
Capitalization
21.29B
11 days until earnings call
Interact to see
Advertisement

BCDA vs SMMT

Header iconBCDA vs SMMT Comparison
Open Charts BCDA vs SMMTBanner chart's image
BioCardia
Price$2.35
Change+$0.04 (+1.73%)
Volume$30.85K
Capitalization12.96M
Summit Therapeutics
Price$28.67
Change+$1.10 (+3.99%)
Volume$1.79M
Capitalization21.29B
BCDA vs SMMT Comparison Chart in %
Loading...
BCDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SMMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCDA vs. SMMT commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCDA is a StrongBuy and SMMT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (BCDA: $2.35 vs. SMMT: $28.67)
Brand notoriety: BCDA and SMMT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCDA: 20% vs. SMMT: 41%
Market capitalization -- BCDA: $12.96M vs. SMMT: $21.29B
BCDA [@Biotechnology] is valued at $12.96M. SMMT’s [@Biotechnology] market capitalization is $21.29B. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCDA’s FA Score shows that 0 FA rating(s) are green whileSMMT’s FA Score has 2 green FA rating(s).

  • BCDA’s FA Score: 0 green, 5 red.
  • SMMT’s FA Score: 2 green, 3 red.
According to our system of comparison, SMMT is a better buy in the long-term than BCDA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCDA’s TA Score shows that 6 TA indicator(s) are bullish while SMMT’s TA Score has 6 bullish TA indicator(s).

  • BCDA’s TA Score: 6 bullish, 3 bearish.
  • SMMT’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, BCDA is a better buy in the short-term than SMMT.

Price Growth

BCDA (@Biotechnology) experienced а +5.38% price change this week, while SMMT (@Biotechnology) price change was +9.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

BCDA is expected to report earnings on May 14, 2025.

SMMT is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SMMT($21.3B) has a higher market cap than BCDA($13M). SMMT YTD gains are higher at: 60.661 vs. BCDA (7.798). BCDA has higher annual earnings (EBITDA): -8.39M vs. SMMT (-235.08M). SMMT has more cash in the bank: 361M vs. BCDA (949K). BCDA has less debt than SMMT: BCDA (850K) vs SMMT (6.45M). BCDA has higher revenues than SMMT: BCDA (3K) vs SMMT (0).
BCDASMMTBCDA / SMMT
Capitalization13M21.3B0%
EBITDA-8.39M-235.08M4%
Gain YTD7.79860.66113%
P/E RatioN/A26.36-
Revenue3K0-
Total Cash949K361M0%
Total Debt850K6.45M13%
FUNDAMENTALS RATINGS
BCDA vs SMMT: Fundamental Ratings
BCDA
SMMT
OUTLOOK RATING
1..100
8481
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
95
Overvalued
PROFIT vs RISK RATING
1..100
10032
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
5237
P/E GROWTH RATING
1..100
1009
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BCDA's Valuation (90) in the null industry is in the same range as SMMT (95) in the Biotechnology industry. This means that BCDA’s stock grew similarly to SMMT’s over the last 12 months.

SMMT's Profit vs Risk Rating (32) in the Biotechnology industry is significantly better than the same rating for BCDA (100) in the null industry. This means that SMMT’s stock grew significantly faster than BCDA’s over the last 12 months.

SMMT's SMR Rating (98) in the Biotechnology industry is in the same range as BCDA (100) in the null industry. This means that SMMT’s stock grew similarly to BCDA’s over the last 12 months.

SMMT's Price Growth Rating (37) in the Biotechnology industry is in the same range as BCDA (52) in the null industry. This means that SMMT’s stock grew similarly to BCDA’s over the last 12 months.

SMMT's P/E Growth Rating (9) in the Biotechnology industry is significantly better than the same rating for BCDA (100) in the null industry. This means that SMMT’s stock grew significantly faster than BCDA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BCDASMMT
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
88%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 17 days ago
79%
Bullish Trend 4 days ago
85%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 9 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
84%
Aroon
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
BCDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SMMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DDEC42.490.09
+0.20%
FT Vest US Equity Dp Bfr ETF Dec
MBNE28.40N/A
+0.02%
SPDR® Nuveen Municipal Bond ESG ETF
IBIE26.13N/A
N/A
iShares iBonds Oct 2028 Term Tips ETF
AVSC54.12-0.71
-1.29%
Avantis US Small Cap Equity ETF
LFGY39.18-0.55
-1.38%
YieldMax Crypto Industry & Tech Portfolio Option Income ETF

BCDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCDA has been closely correlated with SMMT. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if BCDA jumps, then SMMT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCDA
1D Price
Change %
BCDA100%
+1.73%
SMMT - BCDA
68%
Closely correlated
+3.99%
XRTX - BCDA
41%
Loosely correlated
-2.91%
BTAI - BCDA
30%
Poorly correlated
+4.62%
MDGL - BCDA
29%
Poorly correlated
-0.26%
INO - BCDA
28%
Poorly correlated
-2.65%
More